Re:NMDA Receptor Antagonists: Slightly More Than You Wanted ...
by trehalose on Wednesday July 30, 2025 @04:36PM
(#44739191)
CYP2D6 metabolizes DXM into a much more potent NMDA antagonist (dextrorphan, sometimes abbreviated to DXO). Inhibiting it boosts some action(s) of DXM but likely reduces the NMDA antagonist effect.
[ Parent
| on HN ]
There are no comments on this comment yet.